Pharmacosmos hires Chris Olsen DVM

August 29, 2016

Pharmacosmos has hired Chris Olsen DVM, as sales and technical support for Uniferon® 200 mg/mL (Iron(III) Dextran) throughout the United States.

Based near Des Moines, IA, Dr. Olsen will help veterinarians and large commercial swine operations with the prevention and treatment of sub-clinical and full-scale iron deficiency anemia in baby pigs through injectable supplementation of Uniferon® 200 mg/mL. Duties will include further deployment and training for the Uniferon® Farm Anemia Certification and Training (F.A.C.T) program, whereby production managers and swine veterinarians have access to convenient pen-side diagnostic tools and knowledge that eliminate guesswork commonly associated with detection of iron deficiency anemia.

Chris will also serve as the primary liaison to university swine programs, state and national swine associations, spearhead field trials and research, and present relevant research and updates at major swine events.

Olsen is a recent graduate of the College of Veterinary Medicine, Iowa State University, in Ames, IA and already has a wide breadth of experience designing and conducting research trials.

About Uniferon

Uniferon is a modern improved iron hydrogenated dextran based on a natural formula, which is approved for global use:

Uniferon is manufactured without the use of any organic solvents or cyanide, thus, avoiding trace residues of these impurities. Pharmacosmos manufactures iron dextran of high quality and unique purity for customers worldwide. Uniferon is the only injectable iron brand for piglets approved in the EU, the US and Asia.

About Pharmacosmos

Headquartered in Denmark, Pharmacosmos is a family-owned, international healthcare company with more than 50 years of innovation and leadership in iron- and carbohydrate-based treatments and solutions for human and animal use.

A research-based company, its ongoing R&D programme focuses on improving the lives of patients with iron deficiency with or without anaemia. More than 1 billion people live with iron deficiency anaemia and it is the leading cause of death for an estimated 180,000 people every year. This makes it one of the largest global health challenges of our time.

Pharmacosmos has subsidiaries in the Nordics, the UK and the US and its products are marketed in more than 80 countries across the world. Its manufacturing facilities are approved, among others, by the Danish Medicines Agency and the US FDA.